Werewolf Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Werewolf Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Werewolf Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$16.7M, a 101% decline year-over-year.
  • Werewolf Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$62.1M, a 66.6% decline year-over-year.
  • Werewolf Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$37.4M, a 30.6% increase from 2022.
  • Werewolf Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$53.8M, a 7.66% decline from 2021.
  • Werewolf Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$50M, a 232% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$37.4M +$16.4M +30.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$53.8M -$3.83M -7.66% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$50M -$34.9M -232% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$15M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.